Fig. 5From: Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertensionLeast squares mean change from baseline to week 6 in trough sitting clinic systolic blood pressure and sitting clinic diastolic blood pressure by (a) age, (b) sex, and (c) diabetes status. *p < 0.05 compared with placebo; **p < 0.01 compared with placebo; ***p < 0.001 compared with placebo. AZL-M, azilsartan medoxomil; LS, least squares; scDBP, sitting clinic diastolic blood pressure; scSBP, sitting clinic systolic blood pressureBack to article page